“…Biosensor technology has the potential to provide fast and accurate detection of cancer biomarkers (Bohunicky and Mousa, 2010;Chikkaveeraiah et al, 2012;Li et al, 2012;Tothill, 2009;Yang et al, 2014). Among the numerous devices reported, electrochemical biosensors are known to display excellent sensing performances with low detection limits (LD) in the picomolar or femtomolar ranges, notably when associated with electrochemiluminescence (ECL) (Hao et al, 2012;Jie et al, 2010;Lin et al, 2011;Zhang et al, 2012) or electrochemical impedance spectroscopy (EIS) (Li et al, 2005a(Li et al, , 2005bDong et al, 2006;D. Wang et al, 2015) as detection methods.…”